tirzepatide biosimilar EASO Recommends Semaglutide, for First-Line Obesity Therapy Tirzepatide (LY3298176)|CAS 2023788-19-2|DC Chemicals
Pay in 4 interest-free payments of $6.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




























